Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2005
11/23/2005EP0811007B1 Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
11/23/2005CN1701071A Therapeutic agents useful for treating pain
11/23/2005CN1699350A Processes and intermediates for preparing anti-cancer compounds
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/23/2005CN1228037C Method of repairing or restoring damaged or defective hair
11/22/2005US6967248 Crystalline forms of meloxicam and processes for their preparation and interconversion
11/22/2005US6967216 Neuropeptide Y receptor modulators; treating eating disorders
11/22/2005US6967212 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
11/22/2005US6967208 Anticoagulants; cardiovascular disorders
11/22/2005US6967197 Also used in production of tumor necrosis factor alpha
11/17/2005WO2005108396A1 Therapeutic agent for keratoconjunctiva disorder
11/17/2005WO2005108395A1 Ziprasidone hydrochloride polymorph and process for its preparation
11/17/2005WO2005108394A1 Process for the preparation of rosiglitazone
11/17/2005WO2005108389A1 Indole derivatives having piperidine rings
11/17/2005WO2005108384A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
11/17/2005WO2005108382A1 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005108367A1 Compounds for treatment of neurodegenerative diseases
11/17/2005WO2005085177A3 Biaryl amino acids and their use in dna binding oligomers
11/17/2005WO2005073227B1 A process for the preparation of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] phenyl methyl] thiazolidine-2, 4-dione maleate
11/17/2005WO2005058834A3 Quinolines useful in treating cardiovascular disease
11/17/2005WO2005051906A3 Heterocyclic inhibitors of mek and methods of use thereof
11/17/2005US20050256315 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
11/17/2005US20050256310 Therapeutic compounds
11/17/2005US20050256185 Spiro and dispiro 1,2,4-trioxolane antimalarials
11/17/2005US20050256180 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics
11/17/2005US20050256177 Phenyl derivatives for the treatment of abnormal cell growth
11/17/2005US20050256174 Raf kinase inhibitors
11/17/2005US20050256170 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders
11/17/2005US20050256167 Preparation and use of imidazole derivatives for treatment of obesity
11/17/2005US20050256166 Nitrogen-containing compounds
11/17/2005US20050256164 NK1 and NK3 antagonists
11/17/2005US20050256159 1,4-disubstituted piperidine derivatives and their use as 11,betahsd1 inhibitors
11/17/2005US20050256158 PGD2 receptor antagonists for the treatment of inflammatory diseases
11/17/2005US20050256145 Pyrimidine derivatives for the treatment of abnormal cell growth
11/17/2005US20050256139 Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1, 3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same
11/17/2005US20050256136 1-[2-(3-Ethyl-ureido)-3H-benzoimidazol-5-yl]-1H-imiazole-4-carboxylic acid methyl ester; bacteriostatic antibiotic; decrease antibiotic resistance of bacterial organisms; new class of compounds for bacterial infections
11/17/2005US20050256126 for treatment of microbial infections; potent inhibitors of (bMAP) bacterial aminopeptidase
11/17/2005US20050256123 Heterocyclic inhibitors of MEK and methods of use thereof
11/17/2005US20050256122 Substituted pyridazinones
11/17/2005US20050256121 Substituted 2,5-heterocyclic derivatives
11/17/2005US20050256118 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
11/17/2005US20050256117 Ophthalmic compositions for treating ocular hypertension
11/17/2005US20050256111 Pyrimidine derivatives for the treatment of abnormal cell growth
11/17/2005US20050256104 Protease inhibitors
11/17/2005US20050256103 Indole derivative having piperidine ring
11/17/2005US20050256099 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
11/17/2005US20050256098 CGRP receptor antagonists
11/17/2005US20050256066 Fredericamycin derivatives
11/17/2005US20050256031 Composition for relieving discomfort
11/17/2005US20050256030 Heterocyclic self-immolative linkers and conjugates
11/17/2005US20050256003 Novel herbicides
11/17/2005US20050256000 Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use
11/17/2005US20050253112 Luminescent compositions
11/17/2005DE102004020186A1 Heterocyclylessigsäuren als Inhibitoren von TAFla Heterocyclylessigsäuren as inhibitors of TAFIa
11/17/2005DE102004018953A1 4-Halogenalkylpyridin-3-sulfonsäureamide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel 4-haloalkylpyridine-3-sulfonamides, process for their preparation, compositions containing them and their use as pesticides
11/17/2005CA2566352A1 Process for the preparation of rosiglitazone
11/17/2005CA2566098A1 Therapeutic agent for keratoconjunctival disorder
11/17/2005CA2564264A1 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/16/2005EP1594867A2 Phenylacetamides and their use as glucokinase modulators
11/16/2005EP1594866A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives
11/16/2005EP1594865A2 Antibacterial agents
11/16/2005EP1594863A1 Tri(cyclo) substituted amide glucokinase activator compounds
11/16/2005EP1594861A1 Triazole compounds and the therapeutic use thereof
11/16/2005EP1594854A2 Thiazolyl-based compounds useful as kinase inhibitors
11/16/2005EP1594847A2 Substituted azole derivatives as therapeutic agents
11/16/2005EP1594841A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
11/16/2005EP1594505A2 Phenylglycine derivatives useful as serine protease inhibitors
11/16/2005EP1594501A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/16/2005EP1594497A1 Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders
11/16/2005EP1379138B1 Liquid formulations for dermal application in treatment of parasitic insects in animals
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1326850B1 A process for the preparation of bis-benzazolyl compounds
11/16/2005EP1317442B1 Quinolinone derivatives as tyrosine kinase inhibitors
11/16/2005EP1315724B1 A thiazolidinedione derivative and its use as antidiabetic
11/16/2005EP1257550B1 Platelet adp receptor inhibitors
11/16/2005EP1218374B1 Pharmaceutically active sulfonamide derivatives
11/16/2005EP0979227B1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
11/16/2005CN1697830A 嘧啶衍生物 Pyrimidine derivatives
11/16/2005CN1227250C Process for preparing azacycloalkanoyl aminothiazoles
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/16/2005CN1227236C Substituted imidazole neuropeptide YY5 receptor antagonists
11/16/2005CN1227234C Substituted iminoazines
11/16/2005CN1227229C Ethylene derivatives and pest controlling agents containing same
11/16/2005CN1227228C Delta 1-pyrrolines used as pesticides
11/16/2005CN1227012C Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
11/16/2005CN1227008C Method of converting COX-2 inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
11/15/2005US6965034 Deoxygenation of epothilone A or B, to form desoxyepothilone used as nontoxic anticarcinogenic agents
11/15/2005US6964980 Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids
11/15/2005US6964974 2,3-oxidosqualene-lanosterol cyclase inhibitors
11/15/2005US6964973 Nonsteroidal agonists and antagonists
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005CA2330351C New linear or cyclical ureas, their preparation process and the pharmaceutical compositions which contain them
11/15/2005CA2207627C 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
11/10/2005WO2005106459A1 Method of determining ability of drug to bind to troponin i and test drug for the determination
11/10/2005WO2005105794A1 Synthesis of antidiabetic rosiglitazone derivatives
11/10/2005WO2005105793A1 Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure
11/10/2005WO2005105791A1 Indolyl derivatives as liver-x-receptor modulators
11/10/2005WO2005105790A1 4- 2- (cycloalkylamino) pyrimidin-4-yl ! - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
11/10/2005WO2005105788A1 Indole derivatives and use thereof as kinase inhibitors
1 ... 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 ... 628